{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:08:45Z","timestamp":1794506925337,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.semarthrit.2023.152263","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T21:10:00Z","timestamp":1695762600000},"page":"152263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Urine Proteomics Link Complement Activation with Interstitial Fibrosis\/Tubular Atrophy in Lupus Nephritis Patients"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8725-1974","authenticated-orcid":false,"given":"Shudan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vartika","family":"Kesarwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Boderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Aguilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sidoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Greally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Saenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H.","family":"Rovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Michelle Kahlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.semarthrit.2023.152263_bib0001","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/art.38006","article-title":"Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus","volume":"65","author":"Mok","year":"2013","journal-title":"Arthritis and rheumatism"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152263_bib0002","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"The New England journal of medicine"},{"issue":"10289","key":"10.1016\/j.semarthrit.2023.152263_bib0003","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.semarthrit.2023.152263_bib0004","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152263_bib0005","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152263_bib0006","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/art.40575","article-title":"Brief Report: Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated With Tubulointerstitial Inflammation and Renal Scarring","volume":"70","author":"Londono Jimenez","year":"2018","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152263_bib0007","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.1001983","article-title":"In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis","volume":"186","author":"Chang","year":"2011","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152263_bib0008","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.semnephrol.2015.08.007","article-title":"The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis","volume":"35","author":"Clark","year":"2015","journal-title":"Seminars in nephrology"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152263_bib0009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.semarthrit.2017.07.007","article-title":"Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study","volume":"47","author":"Broder","year":"2018","journal-title":"Seminars in arthritis and rheumatism"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152263_bib0010","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/acr.20441","article-title":"Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring","volume":"63","author":"Hsieh","year":"2011","journal-title":"Arthritis care & research"},{"issue":"7 Suppl 2","key":"10.1016\/j.semarthrit.2023.152263_bib0011","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1097\/01.ASN.0000070032.58017.20","article-title":"Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors?","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152263_bib0012","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1681\/ASN.V134928","article-title":"C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys","volume":"13","author":"Nangaku","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152263_bib0013","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1681\/ASN.V10112323","article-title":"Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome","volume":"10","author":"Nangaku","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152263_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000576","article-title":"Membrane attack complex (MAC) deposition in renal tubules is associated with interstitial fibrosis and tubular atrophy: a pilot study","volume":"9","author":"Wang","year":"2022","journal-title":"Lupus science & medicine"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152263_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"issue":"14","key":"10.1016\/j.semarthrit.2023.152263_bib0016","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1111\/bph.15408","article-title":"Role of intracellular complement activation in kidney fibrosis","volume":"178","author":"Portilla","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152263_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040626","article-title":"Expanding the Role of Complement Therapies: The Case for Lupus Nephritis","volume":"10","author":"Li","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152263_bib0018","doi-asserted-by":"crossref","first-page":"F516","DOI":"10.1152\/ajprenal.00604.2016","article-title":"Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis","volume":"312","author":"Xavier","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152263_bib0019","doi-asserted-by":"crossref","first-page":"F1293","DOI":"10.1152\/ajprenal.00357.2019","article-title":"Complement C1r serine protease contributes to kidney fibrosis","volume":"317","author":"Xavier","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semarthrit.2023.152263_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2016.10.010","article-title":"Molecular imaging of the kidney in lupus nephritis to characterize response to treatment","volume":"182","author":"Parikh","year":"2017","journal-title":"Translational Research"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152263_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092532","article-title":"Targeting TGF-\u03b2 Signaling in Kidney Fibrosis","volume":"19","author":"Isaka","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152263_bib0022","doi-asserted-by":"crossref","first-page":"e11021","DOI":"10.15252\/emmm.201911021","article-title":"Dysregulated mesenchymal PDGFR-\u03b2 drives kidney fibrosis","volume":"12","author":"Buhl","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.semarthrit.2023.152263_bib0023","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molimm.2019.07.030","article-title":"Compendium of current complement therapeutics","volume":"114","author":"Zelek","year":"2019","journal-title":"Mol Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152263_bib0024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clim.2013.02.014","article-title":"Targeting the complement system in systemic lupus erythematosus and other diseases","volume":"148","author":"Barilla-Labarca","year":"2013","journal-title":"Clinical immunology (Orlando, Fla)"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152263_bib0025","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis and rheumatism"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152263_bib0026","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152263_bib0027","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney international"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152263_bib0028","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat Methods"},{"issue":"19","key":"10.1016\/j.semarthrit.2023.152263_bib0029","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race","volume":"385","author":"Inker","year":"2021","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.semarthrit.2023.152263_bib0030","unstructured":"H Abdi: Holm's Sequential Bonferroni Procedure. In Neil Salkind (Ed.) EoRDTO, CA: Sage. 2010."},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152263_bib0031","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152263_bib0032","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/art.1780390716","article-title":"Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity","volume":"39","author":"Manzi","year":"1996","journal-title":"Arthritis and rheumatism"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152263_bib0033","first-page":"315","article-title":"Role of ammonia in tubulointerstitial injury","volume":"16","author":"Clark","year":"1990","journal-title":"Mineral and electrolyte metabolism"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152263_bib0034","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI112020","article-title":"Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3","volume":"76","author":"Nath","year":"1985","journal-title":"The Journal of clinical investigation"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152263_bib0035","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.semarthrit.2023.152263_bib0036","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3389\/fimmu.2020.01833","article-title":"Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H","volume":"11","author":"M\u00fchlig","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.semarthrit.2023.152263_bib0037","article-title":"Complement Factor I Variants in Complement-Mediated Renal Diseases","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152263_bib0038","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-021-02605-9","article-title":"Microarray-based analysis of renal complement components reveals a therapeutic target for lupus nephritis","volume":"23","author":"Liu","year":"2021","journal-title":"Arthritis research & therapy"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152263_bib0039","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ekir.2018.04.010","article-title":"Limited Reliability of the Spot Urine Protein\/Creatinine Ratio in the Longitudinal Evaluation of Patients With Lupus Nephritis","volume":"3","author":"Shidham","year":"2018","journal-title":"Kidney international reports"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152263_bib0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2018.01.004","article-title":"Membrane attack complex (mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment","volume":"48","author":"Wang","year":"2018","journal-title":"Seminars in arthritis and rheumatism"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:11:59Z","timestamp":1758733919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"alternative-id":["S0049017223001051"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152263","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine Proteomics Link Complement Activation with Interstitial Fibrosis\/Tubular Atrophy in Lupus Nephritis Patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152263"}}